<DOC>
	<DOC>NCT00959634</DOC>
	<brief_summary>This is a study to investigate the process by which ABT-126 is absorbed, distributed, metabolized and eliminated by the body of a healthy volunteer.</brief_summary>
	<brief_title>Pharmacokinetic Study of ABT-126 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male and female subjects between 18 and 50 years of age If female, subject must be postmenopausal for at least 2 years or surgically sterile (bilateral tubal ligation, bilateral oophorectomy or hysterectomy) If male, subject must be surgically sterile (vasectomy) or agrees to use a barrier method (i.e., condom) of birth control starting on the first day of confinement until 30 days after the last study drug administration Requirement for any overthecounter and/or prescription medication, vitamins and/or herbal supplements on a regular basis History of diabetes, cancer (except basal cell carcinoma of the skin), or any clinically significant cardiovascular, respiratory (except mild asthma), renal, hepatic, gastrointestinal, hematologic, neurologic or psychiatric disease or disorder Presence of any uncontrolled medical illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>